CAS 1352066-68-2: AMG232

Description:AMG232, also known by its chemical name, is a small molecule inhibitor that specifically targets the protein MDM2 (Mouse Double Minute 2 homolog), which is a negative regulator of the p53 tumor suppressor pathway. This compound is classified as an antineoplastic agent and has been investigated for its potential use in cancer therapy, particularly in tumors that express wild-type p53. AMG232 functions by disrupting the interaction between MDM2 and p53, thereby stabilizing p53 and promoting its tumor-suppressive activities, such as inducing cell cycle arrest and apoptosis in cancer cells. The substance is typically characterized by its molecular structure, which includes specific functional groups that facilitate its binding to the MDM2 protein. In preclinical studies, AMG232 has shown promise in various cancer models, leading to ongoing research to evaluate its efficacy and safety in clinical settings. As with many investigational drugs, its pharmacokinetics, dosing, and potential side effects are subjects of active investigation.

Found 4 products.

Product data	Purity	Price range	Estimated delivery
AMG 232 REF: IN-DA009C8ZCAS: 1352066-68-2	98%	To inquire	Fri 11 Apr 25
Navtemadlin REF: TM-TQ0127CAS: 1352066-68-2	95.55% - 98.86%	73.00 €~924.00 €	Mon 21 Apr 25
AMG-232-d7 REF: TR-A576562CAS: 1352066-68-2	- - -	27,041.00 €	Thu 22 May 25
AMG 232 REF: 3D-FC158737CAS: 1352066-68-2	Min. 95%	362.00 €~1,438.00 €	Fri 23 May 25